Peterson S, Assey V, Forsberg B C, Greiner T, Kavishe F P, Mduma B, Rosling H, Sanga A B, Gebre-Medhin M
Department of Women's and Children's Health, Uppsala University, Sweden.
Health Policy Plan. 1999 Dec;14(4):390-9. doi: 10.1093/heapol/14.4.390.
Distribution of oral iodized oil capsules (IOC) is an important intervention in areas with iodine deficiency disorders (IDD) and low coverage of iodized salt. The mean reported coverage of 57 IOC distribution campaigns from 1986-1994 of people aged 1-45 years in 27 districts of Tanzania was 64% (range 20-96%). This declined over subsequent distribution rounds. However, due to delayed repeat distribution, only 43% of person-time was covered, based on the programme objective of giving two IOC (total 400 mg iodine) at 2-year intervals. Three different capsule distribution strategies used in 20 distribution rounds in 1992-1993 were analyzed in depth. Withdrawal of financial support for district distribution expenses under the 'district team' strategy, and the subsequent change to integrated 'primary health care' distribution, increased delays and capsule wastage. The third, more vertical strategy, 'national and district teams', accomplished rapid distribution of IOC about to expire and subsequently a return to the initial 'district team' allowance strategy was made. Annual cost of 'district team' distribution was 26 cents per person (400 mg iodine/2 years). Cost analysis revealed that the IOC itself accounts for more than 90% of total costs at the levels of coverage achieved. IOC will be important in the elimination of IDD in target areas of severe iodine deficiency and insufficient use of iodized salt, provided that high coverage can be achieved. Campaign distribution of medication with high item cost and long distribution intervals may be more cost-effectively performed if separated from regular PHC services at their present resource level. However, motivating health workers and community leaders to do adequate social mobilization remains crucial even if logistics are vertically organized. Insufficient support of distribution expenses and health education may lead to overall wastage of resources.
口服碘油胶囊(IOC)的分发是碘缺乏病(IDD)地区和碘盐覆盖率低的地区的一项重要干预措施。据报告,1986年至1994年在坦桑尼亚27个地区针对1至45岁人群开展的57次IOC分发活动的平均覆盖率为64%(范围为20%至96%)。在随后的分发轮次中,这一覆盖率有所下降。然而,由于重复分发延迟,根据每两年服用两粒IOC(共400毫克碘)的项目目标,仅覆盖了43%的人次。对1992年至1993年20轮分发中使用的三种不同胶囊分发策略进行了深入分析。“地区团队”策略下对地区分发费用的财政支持撤回,随后改为综合“初级卫生保健”分发,导致延迟增加和胶囊浪费。第三种更垂直的策略“国家和地区团队”完成了即将过期的IOC的快速分发,随后又恢复到最初的“地区团队”补贴策略。“地区团队”分发的年成本为每人26美分(每两年400毫克碘)。成本分析表明,在所达到的覆盖水平上,IOC本身占总成本的90%以上。如果能实现高覆盖率,IOC对于消除严重碘缺乏和碘盐使用不足目标地区的碘缺乏病将很重要。如果在目前的资源水平下将高成本项目和长分发间隔的药物活动与常规初级卫生保健服务分开进行,可能会更具成本效益。然而,即使后勤工作是垂直组织的,激励卫生工作者和社区领袖进行充分的社会动员仍然至关重要。对分发费用和健康教育的支持不足可能会导致资源的总体浪费。